Why do some people lose much more weight than others on the same GLP-1 drug
A Phase 2a trial specifically examining metabolic dysfunction-associated steatotic liver disease (MASLD) found that retatrutide at 12 mg reduced liver fat by an extraordinary amount, with some participants achieving complete resolution of fatty liver
A: Yes, BPC-157 is safe to take with most medications
Oral semaglutide might be preferable for someone focused on blood sugar control and comfortable with pill-based therapy, while injectable semaglutide might be better for someone prioritizing weight loss or concerned about gastrointestinal side effects.[1] The authors conclude that more large-scale real-world studies are needed to confirm these findings and explore whether the newer 2 mg once-weekly injectable dose might offer additional benefits.[1] Sources: [1] Pinto M, Brennan L, Diehl K, Lin S, Heacock S
For weight management, semaglutide (Wegovy) follows a different schedule: 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, and finally 2.4 mg weekly